647 related articles for article (PubMed ID: 26794398)
1. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
[TBL] [Abstract][Full Text] [Related]
2. A combination of doxycycline and ribavirin alleviated chikungunya infection.
Rothan HA; Bahrani H; Mohamed Z; Teoh TC; Shankar EM; Rahman NA; Yusof R
PLoS One; 2015; 10(5):e0126360. PubMed ID: 25970853
[TBL] [Abstract][Full Text] [Related]
3. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of a peptide-fusion protein (Latarcin-PAP1-Thanatin) against chikungunya virus.
Rothan HA; Bahrani H; Shankar EM; Rahman NA; Yusof R
Antiviral Res; 2014 Aug; 108():173-80. PubMed ID: 24929084
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of nobiletin against chikungunya virus in vitro.
Lin SC; Chen MC; Li S; Lin CC; Wang TT
Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
[TBL] [Abstract][Full Text] [Related]
6. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
[TBL] [Abstract][Full Text] [Related]
7. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
[TBL] [Abstract][Full Text] [Related]
8. Development of a Real-Time Cell Analysing (RTCA) method as a fast and accurate screen for the selection of chikungunya virus replication inhibitors.
Marlina S; Shu MH; AbuBakar S; Zandi K
Parasit Vectors; 2015 Nov; 8():579. PubMed ID: 26553263
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of silymarin against chikungunya virus.
Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K
Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201
[TBL] [Abstract][Full Text] [Related]
10. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus.
Rothan HA; Buckle MJ; Ammar YA; Mohammadjavad P; Shatrah O; Noorsaadah AR; Rohana Y
Trop Biomed; 2013 Dec; 30(4):681-90. PubMed ID: 24522138
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines.
Franco EJ; Rodriquez JL; Pomeroy JJ; Hanrahan KC; Brown AN
Antivir Chem Chemother; 2018; 26():2040206618807580. PubMed ID: 30354193
[TBL] [Abstract][Full Text] [Related]
12. Activity of andrographolide against chikungunya virus infection.
Wintachai P; Kaur P; Lee RC; Ramphan S; Kuadkitkan A; Wikan N; Ubol S; Roytrakul S; Chu JJ; Smith DR
Sci Rep; 2015 Sep; 5():14179. PubMed ID: 26384169
[TBL] [Abstract][Full Text] [Related]
13. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
[TBL] [Abstract][Full Text] [Related]
14. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
Henß L; Beck S; Weidner T; Biedenkopf N; Sliva K; Weber C; Becker S; Schnierle BS
Virol J; 2016 Aug; 13(1):149. PubMed ID: 27581733
[TBL] [Abstract][Full Text] [Related]
15. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses.
Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T
Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081
[TBL] [Abstract][Full Text] [Related]
16. Suramin Inhibits Chikungunya Virus Entry and Transmission.
Ho YJ; Wang YM; Lu JW; Wu TY; Lin LI; Kuo SC; Lin CC
PLoS One; 2015; 10(7):e0133511. PubMed ID: 26208101
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activity of stearylamine against chikungunya virus.
Jeengar MK; Kurakula M; Patil P; More A; Sistla R; Parashar D
Chem Phys Lipids; 2021 Mar; 235():105049. PubMed ID: 33422549
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
[TBL] [Abstract][Full Text] [Related]
19. A Real-Time Cell Analyzing Assay for Identification of Novel Antiviral Compounds against Chikungunya Virus.
Zandi K
Methods Mol Biol; 2016; 1426():255-62. PubMed ID: 27233278
[TBL] [Abstract][Full Text] [Related]
20. The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection.
Weber C; Sliva K; von Rhein C; Kümmerer BM; Schnierle BS
Antiviral Res; 2015 Jan; 113():1-3. PubMed ID: 25446334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
